(Q37267048)

19 August 2017

Population-based study on use of chemotherapy in men with castration resistant prostate cancer (English)

1 reference

19 August 2017

1 reference

1 reference

2

Hans Garmo

1 reference

19 August 2017

4

Pär Stattin

1 reference

19 August 2017

Ingela Franck Lissbrant

series ordinal

1

1 reference

PMCID

3812701

19 August 2017

Anders Widmark

series ordinal

3

1 reference

19 August 2017

21 February 2013

1 reference

19 August 2017

1 reference

19 August 2017

52

1 reference

19 August 2017

8

1 reference

19 August 2017

1593-1601

1 reference

Management of advanced prostate cancer in senior adults: the new landscape

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Optimizing the management of prostate cancer in senior adults: call to action

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Challenges in the management of older patients with colon cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Characterising the castration-resistant prostate cancer population: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Chemotherapy-based treatment for castration-resistant prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Factors affecting receipt of chemotherapy in women with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

NCCN clinical practice guidelines in oncology: prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Chemotherapy for older patients with prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Chemotherapy use at the end of life. A retrospective single centre experience analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Age and clinical decision making in oncology patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812701

Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden

3 September 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770164

Regional differences in treatment and outcome in non-small cell lung cancer: A population-based study (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770164

Differences according to educational level in the management and survival of colorectal cancer in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770164

Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770164

A population-based study of prostate cancer chemotherapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23427879

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23427879

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reliability of death certificates in prostate cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23427879

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/0284186X.2013.770164

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

PMCID

3812701